Scott Levine, The Motley Fool
4 min read
Limping toward the end of 2026, Centrus Energy (NYSE:LEU) stock fell 18.6% in September and continued to decline last month. Analysts took a more bearish stance on the nuclear stock, and investors were clearly paying attention.
According to data provided by S&P Global Market Intelligence, Centrus Energy stock fell 26% in October, while the S&P 500 dipped 0.5%.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a “Double Down” signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same “Total Conviction” signal is flashing for a company 1/100th the size of Nvidia. Continue »
Image source: Getty Images.
Firms are skeptical of the company’s acquisition of a key supplier
On Oct. 19, Centrus announced its acquisition of Westerman Holdings, which the company characterizes as one of its largest and most diversified suppliers. Centrus believes that the transaction, funded with about $95 million in cash and $21 million in equity, will contribute to its adjusted earnings per share in the first year following its closing.
Centrus lauded the acquisition as “a significant milestone … as it builds supply chain resilience while diversifying its revenue base.” Westerman provides Centrus to a variety of industries beyond nuclear, including oil and gas and other industrial sectors.
Investors immediately expressed their disapproval of the acquisition. Centrus shares dropped more than 4% on Oct. 19 from the stock’s previous close.
On Oct. 20, analysts began to weigh in on the acquisition — and the opinions were hardly encouraging. Roth Capital slashed its price target on Centrus to $115 from $188, maintaining a neutral rating. According to Thefly.com, the firm updated its model after Centrus acquired Westerman Holdings and believes that the company’s third-quarter financial results could disappoint investors.
In the ensuing days, firms shared a variety of other downwardly revised price targets.
-
On Oct. 20, Barclays lowered its price target to $150 from $207.
-
On Oct. 23, UBS dropped its price target to $120 from $185.
-
On Oct. 26, JPMorgan reduced its price target to $120 from $180.
Centrus is a leading provider of nuclear fuel and services for the nuclear power industry. One area in which the company distinguishes itself is the production of high-assay low-enriched uranium (HALEU), a specialized form of nuclear fuel required by small modular reactors (SMRs), the next generation of nuclear reactors. At the end of September 2026, Centrus reported a backlog of $5.4 billion for both low-enriched uranium (LEU) and HALEU businesses.
